Mississippi's Right-to-Try expressly includes adult mesenchymal stem cells.
Statute
MS SB 2830 (2020)
Effective
Effective 2020
Mississippi expanded its Right-to-Try statute in 2020 to include adult mesenchymal stem cells (MSCs) extracted from bone marrow, indicated for debilitating disability, traumatic injury, or terminal illness with mandatory written informed consent.
The requirements below are set by MS SB 2830 (2020). Compliance is the responsibility of each individual treating physician under their state license.
Statutory compliance does not equal FDA approval. The procedures discussed are investigational and have not been approved by the US Food and Drug Administration.
Mississippi has enacted MS SB 2830 (2020), which sets out specific conditions under which a state-licensed physician may practice in this area. The procedures discussed here are investigational and have not been approved by the US Food and Drug Administration.
No. Adults may travel to Mississippi from any US state for an in-person consultation with a network physician. Whether any procedure is appropriate is a clinical decision determined by the treating physician.
Cost depends on the indication, the cell product, and the treating physician. Each physician sets their own pricing and provides a written estimate. Select Stem Cell does not collect medical fees on behalf of physicians.
Yes. Mississippi law requires the treating physician to provide written disclosure of investigational status and obtain informed consent prior to any procedure.
Continue Reading
We use cookies
We use strictly necessary cookies to make this site work, and (with your permission) functional and analytics cookies to improve your experience. We do not use marketing or behavioral-advertising cookies. Read our Cookie Policy.